OpenAI· @OpenAI · X·· 8 小时前AI 评分58
AI 导读
OpenAI 宣布收购 Orchestra Bio，后者是帮助生物医药团队协调药物研发复杂流程的平台。OpenAI 表示将基于其生命科学研究模型与工具 Rosalind 整合这些运营能力，让新疗法更快到达患者。Orchestra Bio 创始人 Ashok Raj 及团队一同加入。
正文
We’ve acquired Orchestra Bio, a platform that helps biopharma teams coordinate the complex process of drug development.
Together, we’ll build on Rosalind, our AI models and tools for life sciences research, to streamline those operations and help new treatments reach patients sooner.
Welcome @ashokaraj_ and team!
https://openai.com/index/openai-to-acquire-orchestra-bio/
来源：OpenAI · x.com